Hacking the Code of Amyloid Formation

References

• Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314:777 - 781
   PubMed Web of Science ®Google Scholar
• Pastor MT, Esteras-Chopo A, Lopez de la Paz M. Design of model systems for amyloid formation: Lessons for prediction and inhibition. Curr Opin Struct Biol 2005; 15:57 - 63
   PubMed Web of Science ®Google Scholar
• Baldwin AJ, Bader R, Christodoulou J, MacPhee CE, Dobson CM, Barker PD. Cytochrome display on amyloid fibrils. J Am Chem Soc 2006; 128:2162 - 2163
   PubMed Web of Science ®Google Scholar
• Glenner GG, Ein D, Eanes ED, Bladen HA, Terry W, Page DL. Creation of “amyloid” fibrils from Bence Jones proteins in vitro. Science 1971; 174:712 - 714
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975; 81:101 - 116
   PubMed Web of Science ®Google Scholar
• Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24:329 - 332
   PubMed Web of Science ®Google Scholar
• Kelly JW. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 1998; 8:101 - 106
   PubMed Web of Science ®Google Scholar
• Rochet JC, Lansbury PT Jr. Amyloid fibrillogenesis: Themes and variations. Curr Opin Struct Biol 2000; 10:60 - 68
   PubMed Web of Science ®Google Scholar
• Harper JD, Lansbury PT Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997; 66:385 - 407
   PubMed Web of Science ®Google Scholar
• Smith AM, Jahn TR, Ashcroft AE, Radford SE. Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. J Mol Biol 2006; 364:9 - 19
   PubMed Web of Science ®Google Scholar
• Mastrangelo IA, Ahmed M, Sato T, Liu W, Wang C, Hough P, Smith SO. High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol 2006; 358:106 - 119
   PubMed Web of Science ®Google Scholar
• Makin OS, Serpell LC. Structures for amyloid fibrils. Febs J 2005; 272:5950 - 5961
   PubMed Web of Science ®Google Scholar
• Blake CC, Geisow MJ, Oatley SJ, Rerat B, Rerat C. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol 1978; 121:339 - 356
   PubMed Web of Science ®Google Scholar
• Artymiuk PJ, Blake CC. Refinement of human lysozyme at 1.5 A resolution analysis of non-bonded and hydrogen-bond interactions. J Mol Biol 1981; 152:737 - 762
   PubMed Web of Science ®Google Scholar
• Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB. Amyloid beta-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates. J Biol Chem 1999; 274:25945 - 25952
   PubMed Web of Science ®Google Scholar
• Kayed R, Bernhagen J, Greenfield N, Sweimeh K, Brunner H, Voelter W, Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 1999; 287:781 - 796
   PubMed Web of Science ®Google Scholar
• Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 1996; 35:13709 - 13715
   PubMed Web of Science ®Google Scholar
• Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem 1994; 269:24290 - 24297
   PubMed Web of Science ®Google Scholar
• Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999; 96:3590 - 3594
   PubMed Web of Science ®Google Scholar
• Fandrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001; 410:165 - 166
   PubMed Web of Science ®Google Scholar
• Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 1998; 95:4224 - 4228
   PubMed Web of Science ®Google Scholar
• Esteras-Chopo A, Serrano L, Lopez de la Paz M. The amyloid stretch hypothesis: Recruiting proteins toward the dark side. Proc Natl Acad Sci USA 2005; 102:16672 - 16677
   PubMed Web of Science ®Google Scholar
• Fezoui Y, Hartley DM, Walsh DM, Selkoe DJ, Osterhout JJ, Teplow DB. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat Struct Biol 2000; 7:1095 - 1099
   PubMedGoogle Scholar
• López de la Paz M, Goldie K, Zurdo J, Lacroix E, Dobson CM, Hoenger A, Serrano L. De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci USA 2002; 99:16052 - 16057
   PubMed Web of Science ®Google Scholar
• Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 1997; 273:729 - 739
   PubMed Web of Science ®Google Scholar
• Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002; 416:507 - 511
   PubMed Web of Science ®Google Scholar
• Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, Chiti F, Dobson CM, Stefani M. Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci 2006; 26:8160 - 8167
   PubMed Web of Science ®Google Scholar
• Kranenburg O, Kroon-Batenburg LM, Reijerkerk A, Wu YP, Voest EE, Gebbink MF. Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro. FEBS Lett 2003; 539:149 - 155
   PubMed Web of Science ®Google Scholar
• Dobson CM. Protein folding and its links with human disease. Biochem Soc Symp 2001; 00:1 - 26
   Google Scholar
• Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA 2002; 99:Suppl 4 16419 - 16426
   PubMed Web of Science ®Google Scholar
• Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003; 424:805 - 808
   PubMed Web of Science ®Google Scholar
• Uversky VN, Gillespie JR, Fink AL. Why are “natively unfolded” proteins unstructured under physiologic conditions?. Proteins 2000; 41:415 - 427
   PubMed Web of Science ®Google Scholar
• Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 2004; 101:10584 - 10589
   PubMed Web of Science ®Google Scholar
• Jones S, Manning J, Kad NM, Radford SE. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. J Mol Biol 2003; 325:249 - 257
   PubMed Web of Science ®Google Scholar
• Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H, Kapurniotu A. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 2000; 295:1055 - 1071
   PubMed Web of Science ®Google Scholar
• Tjernberg LO, Naslund J, Lindqvist F, Johansson J, Karlstrom AR, Thyberg J, Terenius L, Nordstedt C. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 1996; 271:8545 - 8548
   PubMed Web of Science ®Google Scholar
• Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson CM, Aviles FX, Serrano L. Short amino acid stretches can mediate amyloid formation in globular proteins: The Src homology 3 (SH3) case. Proc Natl Acad Sci USA 2004; 101:7258 - 7263
   PubMed Web of Science ®Google Scholar
• von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci USA 2000; 97:5129 - 5134
   PubMed Web of Science ®Google Scholar
• López de la Paz M, Serrano L. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 2004; 101:87 - 92
   PubMed Web of Science ®Google Scholar
• Azriel R, Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide: An experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem 2001; 276:34156 - 34161
   PubMed Web of Science ®Google Scholar
• Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005; 435:773 - 778
   PubMed Web of Science ®Google Scholar
• Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, Eisenberg D. The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA 2006; 103:4074 - 4078
   PubMed Web of Science ®Google Scholar
• Pawar AP, Dubay KF, Zurdo J, Chiti F, Vendruscolo M, Dobson CM. Prediction of “aggregation-prone” and “aggregation-susceptible” regions in proteins associated with neurodegenerative diseases. J Mol Biol 2005; 350:379 - 392
   PubMed Web of Science ®Google Scholar
• Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 2004; 22:1302 - 1306
   PubMed Web of Science ®Google Scholar
• Rousseau F, Schymkowitz J, Serrano L. Protein aggregation and amyloidosis: Confusion of the kinds?. Curr Opin Struct Biol 2006; 16:118 - 126
   PubMed Web of Science ®Google Scholar
• Tanaka M, Machida Y, Nishikawa Y, Akagi T, Morishima I, Hashikawa T, Fujisawa T, Nukina N. The effects of aggregation-inducing motifs on amyloid formation of model proteins related to neurodegenerative diseases. Biochemistry 2002; 41:10277 - 10286
   PubMed Web of Science ®Google Scholar
• Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, Wickner RB, Steven AC. Architecture of Ure2p prion filaments: The N-terminal domains form a central core fiber. J Biol Chem 2003; 278:43717 - 43727
   PubMed Web of Science ®Google Scholar
• Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ. Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat Biotechnol 2001; 19:131 - 136
   PubMed Web of Science ®Google Scholar
• He Y, Tang H, Yi Z, Zhou H, Luo Y. Fibrillogenesis of apomyoglobin facilitated by aggregation sequence of yeast Sup35 in various regions. FEBS Lett 2005; 579:1503 - 1508
   PubMed Web of Science ®Google Scholar
• Chae YK, Cho KS, Chun W. A prionogenic peptide derived from Sup35 can force the whole GST fusion protein to show amyloid characteristics. Protein Pept Lett 2002; 9:315 - 321
   PubMed Web of Science ®Google Scholar
• Ventura S, Lacroix E, Serrano L. Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. J Mol Biol 2002; 322:1147 - 1158
   PubMed Web of Science ®Google Scholar
• Musacchio A, Noble M, Pauptit R, Wierenga R, Saraste M. Crystal structure of a Src-homology 3 (SH3) domain. Natur 1992; 359:851 - 855
   PubMed Web of Science ®Google Scholar
• McParland VJ, Kalverda AP, Homans SW, Radford SE. Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat Struct Biol 2002; 9:326 - 331
   PubMedGoogle Scholar
• Chiti F, Taddei N, Baroni F, Capanni C, Stefani M, Ramponi G, Dobson CM. Kinetic partitioning of protein folding and aggregation. Nat Struct Biol 2002; 9:137 - 143
   PubMedGoogle Scholar
• Monti M, Garolla di Bard BL, Calloni G, Chiti F, Amoresano A, Ramponi G, Pucci P. The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. J Mol Biol 2004; 336:253 - 262
   PubMed Web of Science ®Google Scholar
• Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 1998; 5:55 - 66
   PubMed Web of Science ®Google Scholar
• Huff ME, Page LJ, Balch WE, Kelly JW. Gelsolin domain 2 Ca2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of finnish type. J Mol Biol 2003; 334:119 - 127
   PubMed Web of Science ®Google Scholar
• Chen CD, Huff ME, Matteson J, Page L, Phillips R, Kelly JW, Balch WE. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. Embo J 2001; 20:6277 - 6287
   PubMed Web of Science ®Google Scholar
• Sambashivan S, Liu Y, Sawaya MR, Gingery M, Eisenberg D. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 2005; 437:266 - 269
   PubMed Web of Science ®Google Scholar
• Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, Hasnain SS, Hayward LJ, Valentine JS, Yeates TO, Hart PJ. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol 2003; 10:461 - 467
   PubMedGoogle Scholar
• Aitken A. Protein consensus sequence motifs. Mol Biotechnol 1999; 12:241 - 253
   PubMed Web of Science ®Google Scholar
• House CM, Frew IJ, Huang HL, Wiche G, Traficante N, Nice E, Catimel B, Bowtell DD. A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci USA 2003; 100:3101 - 3106
   PubMedGoogle Scholar
• Hamodrakas SJ, Hoenger A, Iconomidou VA. Amyloid fibrillogenesis of silkmoth chorion protein peptide-analogues via a liquid-crystalline intermediate phase. J Struct Biol 2004; 145:226 - 235
   PubMed Web of Science ®Google Scholar
• Osherovich LZ, Weissman JS. The utility of prions. Dev Cell 2002; 2:143 - 151
   PubMed Web of Science ®Google Scholar
• Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB. Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci USA 2005; 102:10575 - 10580
   PubMed Web of Science ®Google Scholar
• Huff ME, Balch WE, Kelly JW. Pathological and functional amyloid formation orchestrated by the secretory pathway. Curr Opin Struct Biol 2003; 13:674 - 682
   PubMed Web of Science ®Google Scholar
• Citron M. Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 2004; 5:677 - 685
   PubMed Web of Science ®Google Scholar
• Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4:49 - 60
   PubMed Web of Science ®Google Scholar